News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Averion And ProMedica CRC, Inc. Sign Alliance Agreement For Complementary Promotion And Support Of Clinical Trials

10/19/2005 5:09:49 PM

FRAMINGHAM, Mass. & BOSTON--(BUSINESS WIRE)--Jan. 28, 2004--Averion Inc. (Averion) a leading Contract Research Organization with more than 20 years experience, announced today that it has signed a non-exclusive alliance agreement with ProMedica Clinical Research Center, Inc. (ProMedica CRC). ProMedica CRC is a provider of Phase I and Phase II services.

This Agreement represents a working relationship that will involve joint marketing efforts and a mutual contracting of complementary products and services from both companies to biotechnology, pharmaceutical and medical device companies.

Among the areas where a collaborative relationship would appear to be beneficial to both parties are cases when Averion requires support of Phase I or II studies where Averion does not provide such support and where ProMedica CRC requires clinical monitoring, data management, biostatistics or medical writing support.

"We are continuously striving to develop our Strategic Alliance Network to better serve our clients needs," Brian Langin, Senior Manager of Business Development and Strategic Alliances said. "We feel that ProMedica CRC will provide our mutual clients with a continued high level of service."

About Averion:

Averion provides clinical trials support for biotech, pharmaceutical and medical device companies in the design, execution and reporting of clinical trials. Services include Program Planning, Study Design, Clinical Monitoring, Medical Monitoring, Data Management, Database Development, Biometrics, Medical Writing, Data Monitoring Committees, Compliance and Validation, and FDA Representation. Averion's service uniqueness is based on the integrity of the processes supporting them and the personal commitment of the individuals on staff.

Averion's corporate headquarters are located in Framingham, Massachusetts. Along with its alliance partners, Averion supports clinical trials throughout North America and Europe. Visit Averion's web site at

About ProMedica CRC:

ProMedica Clinical Research Center, Inc., a spin-off of the former MTRA group, is a Phase I-II research unit which provides over 30 years of experience. Miguel A. Zinny, MD, who is a board certified internist/gastroenterologist, continues as the Medical Director. ProMedica CRC offers quality patient recruitment of healthy volunteers and patient populations, IRB affiliations for timely approvals and access to medical experts and consultant's from Boston's medical community.

ProMedica CRC is located in Boston, MA. Visit ProMedica's website at


Averion contacts: Senior Manager, Business Development and Strategic Alliances Brian Langin, 508-416-2829 or Communications Specialist Gillian Marlette (Media), 508-416-2638 or ProMedica contact: Director, Business Development Richard H. Ferraro, DMD, MPH, EdM, 617-782-6872 x22

Source: Averion

Read at

comments powered by Disqus